SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-032655
Filing Date
2014-09-26
Accepted
2014-09-26 11:49:35
Documents
1
Period of Report
2014-09-23

Document Format Files

Seq Description Document Type Size
1 ANNUAL DIRECTOR GRANT rrd416680.html 4  
1 ANNUAL DIRECTOR GRANT rrd416680.xml 4 3732
  Complete submission text file 0001181431-14-032655.txt   5330
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DANCE BIOPHARM INC. 150 NORTH HILL DRIVE, SUITE 24 BRISBANE CA 94005
Business Address
Krivulka Joseph J (Reporting) CIK: 0001296750 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24006 | Film No.: 141123039